Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2012
Date:1/25/2012

ts, including those located in Japan; the company's ability to maintain or increase margins; the impact of competitive products and pricing; the potential loss of key distributors or key personnel; challenges to public tender awards and the loss of such awards or other orders; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

A summary of earnings and other financial information follows.Varian Medical Systems, Inc. and Subsidiaries Consolidated Statements of Earnings
(Unaudited)(Dollars and shares in millions, except per share amounts)Q1 QTR2012Q1 QTR2011Net orders

$

606.1$

592.8  Oncology Systems484.7459.0  X-Ray Products109.8111.9  Security & Inspection Products10.821.3  Varian Particle Therapy 0.60.6  Ginzton Technology Center 0.2-Order backlog

$

2,510.2$

2,205.6Revenues    

$

625.3$

579.9  Oncology Systems487.6452.4  X-Ray Products113.0111.6  Other24.715.9Cost  of  revenues

$

356.5$

313.1Gross margin   268.8266.8
As a percent of revenues
43.0%46.0%Operating expenses    Research and development43.838.5  Selling, general and administrative  96.191.3Operating earnings128.9137.0
As a percent of revenues
20.6%23.6%Interest income, net0.30.1Earnings before taxes129.2137.1Taxes on earnings  39.040.6Net earnings  

$

90.2$

96.5   As a percent of revenues14.4%16.6%Net earnings per share – basic

$

0.80$

0.82Net ear
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015  Research ... addition of the "An Introduction to the ... 2015)" conference to their offering. ... the European medical device legislation. It will explain ... involvement of Notified Bodies, how to choose one ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has ... Legislation (London, UK - November 16-17, 2015)" conference ... EU modules concerning Pharmacovigilance are a major departure in ... Europe . The intention of the course ... examine how they overlap and fit together and what ...
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2
... , , HOUSTON, Nov. 16 Cyberonics, Inc. ... to its tax position. , In its fiscal second quarter ... GAAP tax benefit of approximately $40 million resulting from the ... losses. The recognition of this tax benefit follows from ...
... , , LOS ANGELES, Nov. ... a 40-year-old Indian rhinoceros, has successfully completed treatment for ... to deliver electronic, x-ray based therapy directly to cancer ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091116/SF11909 ) , Randa was ...
Cached Medicine Technology:Cyberonics Provides Update on Tax Position 2Cyberonics Provides Update on Tax Position 3Cyberonics Provides Update on Tax Position 4L.A. Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 2L.A. Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 3
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world leader ... spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof at ... at the Olympia London, booth #F33 , Be the first to get a sneak ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... speakers for its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly ... as CVS Health, Express Scripts and Milliman, will discuss how plan sponsors are ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Hunters Creek ... Survivor Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited ... for friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
(Date:9/3/2015)... ... 2015 , ... ProScrub is a set of automated tools that allow Final ... speed effects without the use of keyframes. Utilize ProScrub's powerful sliders to determine ... perfect complements to energetic video productions. ProScrub is a Final Cut Pro ...
(Date:9/3/2015)... ... ... an unavoidable result of incision or injury to the skin. Unsightly as it may be, ... of a scar is dependent on many factors – the size and depth of the ... near invisibility on their own over a period of months,” says Dr. Jocelyn Lieb ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4
... relative of the highly pathogenic avian influenza virus (H5N1) ... including// chlorination, ultraviolet (UV) radiation and bacterial digesters. The ... case of the pathways by which the influenza could ... related virus, called H5N2, to see whether a hypothetical ...
... Although it’s our most vital organ, surprisingly little ... That makes it harder to uncover what’s gone ... other brain-associated disorders, and ultimately, it often leaves ... such as Alzheimer’s and Parkinson’s disease, schizophrenia, attention ...
... management of the health service has been revealed by the ... nurses, measly pay rises// and strikes. ,A copy ... reveals that 37000 posts are in danger as the Government ... 2.7 per cent cut in the workforce. ,NHS ...
... circumcision procedure could reduce 50% of the HIV infection rate ... number of Ugandan men seeking it.// , ... reports, out of which nearly half were adults. Less than ... Institutes of Health found that new HIV infections among circumcised ...
... international homeopathy conference is taking place in this Taj ... and eight countries.// ,The four-day meet, which ... AIDS and "other difficult subjects which have proved a ... secretary, told IANS., ,The slogan of the conference ...
... surgical team was led by Dr. Christopher Moir at Minnesota's ... North Dakota// (ND) and now they are on the challenging ... Madysen Fitterer, the twin girls born on Aug. 8 to ... the chest - were both doing very well following the ...
Cached Medicine News:Health News:Avian Flu Unlikely to Spread Through Water Systems 2Health News:Researchers Looking for Genes That Control the Brain 2Health News:A Secret Dossier Predicts Major Changes At NHS, England 2
... A new Transnasal Lacrimal Stent has been ... B. Becker, M.D., the Transnasal Lacrimal Stent addressed ... and other forms of endoscopic DCR. Brought in ... relatively large diameter. Because there is no need ...
...
... electrophysiology system is the Espion. This is an ... wide variety of stimulators for different types of ... ,The Espion system was designed from the ... standard clinical visual function tests, ERG, VEP, PERG, ...
... SIREMOBIL Iso-C3D is based on SIREMOBIL ... the industry. In the intra-operative 3D-Mode, the ... the motorized 190 orbital movement. This allows ... in greater precision during the procedure. This ...
Medicine Products: